{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:08:52Z","timestamp":1758632932189},"reference-count":46,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.pcad.2017.12.003","type":"journal-article","created":{"date-parts":[[2017,12,24]],"date-time":"2017-12-24T01:10:31Z","timestamp":1514077831000},"page":"500-507","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"60","author":[{"given":"Abhishek","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakash","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sammy","family":"Elmariah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Drachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chukwudi","family":"Obiagwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Vallakati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samin K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl J.","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debabrata","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio G.","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Feres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Marmur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Helft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2017.12.003_bb0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0735-1097(00)00732-4","article-title":"Management of coronary artery disease: therapeutic options in patients with diabetes","volume":"36","author":"Hammoud","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0010","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/01.CIR.96.6.1761","article-title":"Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI)","volume":"96","author":"The BARI investigators","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2017.12.003_bb0015","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jacc.2015.05.053","article-title":"Duration of dual antiplatelet therapy after coronary stenting: a review of the evidence","volume":"66","author":"Montalescot","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0020","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0025","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2017.12.003_bb0030","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/eurheartj\/ehu523","article-title":"ISAR-SAFE: a randomized, double-blind, placebo controlled trial of 6 vs. 12\u202fmonths of clopidogrel therapy after drug-eluting stenting","volume":"36","author":"Schulz-Sch\u00fcpke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2017.12.003_bb0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2017.12.003_bb0040","first-page":"365","article-title":"Stopping or continuing clopidogrel 12\u202fmonths after drug-eluting stent placement: the OPTIDUAL randomized trial","volume":"37","author":"Helft","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2017.12.003_bb0045","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(14)60612-7","article-title":"Dual-antiplatelet treatment beyond 1\u202fyear after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial","volume":"384","author":"Collet","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2017.12.003_bb0050","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.113.003303","article-title":"Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial","volume":"129","author":"Lee","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2017.12.003_bb0055","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30\u202fmonths of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2017.12.003_bb0060","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacc.2015.01.039","article-title":"Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials","volume":"65","author":"Giustino","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0065","doi-asserted-by":"crossref","first-page":"h1618","DOI":"10.1136\/bmj.h1618","article-title":"Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials","volume":"350","author":"Navarese","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.pcad.2017.12.003_bb0070","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0140-6736(15)60263-X","article-title":"Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials","volume":"385","author":"Palmerini","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2017.12.003_bb0075","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0140-6736(14)62052-3","article-title":"Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis","volume":"385","author":"Elmariah","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2017.12.003_bb0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.amjcard.2014.04.035","article-title":"Meta-analysis of randomized clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stents","volume":"114","author":"El-Hayek","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijcard.2016.04.118","article-title":"Duration of dual antiplatelet therapy after various drug-eluting stent implantation","volume":"215","author":"Sharma","year":"2016","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.pcad.2017.12.003_bb0090","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.mayocp.2016.06.004","article-title":"Duration of dual antiplatelet therapy after drug-eluting stent implantation in patients with and without acute coronary syndrome: a systematic review of randomized controlled trials","volume":"91","author":"Sharma","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pcad.2017.12.003_bb0095","article-title":"Duration of dual antiplatelet therapy following drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials","author":"Sharma","year":"2018","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0100","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2014.12.046","article-title":"Short- versus longterm dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0105","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"issue":"17","key":"10.1016\/j.pcad.2017.12.003_bb0110","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2017.12.003_bb0115","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0120","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117\u202f762\u202fpatient-years of follow-up from randomized trials","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2017.12.003_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2013.10.006","article-title":"Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study","volume":"170","author":"Simsek","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/heartjnl-2013-304933","article-title":"Incidence and predictors of restenosis after coronary stenting in 10\u202f004 patients with surveillance angiography","volume":"100","author":"Cassese","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2017.12.003_bb0135","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1161\/01.CIR.0000129767.45513.71","article-title":"Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloonexpandable stent in the treatment of patients with de novo coronary artery lesions) substudy","volume":"109","author":"Moussa","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2017.12.003_bb0140","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0735-1097(01)01555-8","article-title":"Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control","volume":"38","author":"Osende","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0145","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1160\/th14-05-0468","article-title":"The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease","volume":"112","author":"Neergaard-Petersen","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pcad.2017.12.003_bb0150","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1161\/HYPERTENSIONAHA.111.181404","article-title":"Suboptimal inhibition of platelet cyclooxygenase-1 by aspirin in metabolic syndrome","volume":"59","author":"Smith","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2017.12.003_bb0155","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.2337\/db07-0707","article-title":"The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study","volume":"56","author":"DiChiara","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.pcad.2017.12.003_bb0160","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1210\/jc.2009-2392","article-title":"Aspirin resistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes mellitus","volume":"95","author":"Ertugrul","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pcad.2017.12.003_bb0165","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jacc.2016.11.050","article-title":"Enteric coating and aspirin nonresponsiveness in patients with type 2 diabetes mellitus","volume":"69","author":"Bhatt","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0170","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/jama.293.12.1501","article-title":"Diabetes and coronary revascularization","volume":"293","author":"Flaherty","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2017.12.003_bb0175","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1\u202fyear after percutaneous coronary intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2017.12.003_bb0180","doi-asserted-by":"crossref","first-page":"i5483","DOI":"10.1136\/bmj.i5483","article-title":"Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials","volume":"355","author":"Gargiulo","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.pcad.2017.12.003_bb0185","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/01.CIR.0000089189.70578.E2","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II","volume":"108","author":"Luscher","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2017.12.003_bb0190","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.jacc.2008.01.063","article-title":"Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions","volume":"51","author":"Brar","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0195","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1160\/TH08-03-0136","article-title":"Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease","volume":"100","author":"Serebruany","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pcad.2017.12.003_bb0200","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.109.913376","article-title":"Diabetes and antiplatelet therapy in acute coronary syndrome","volume":"123","author":"Ferreiro","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2017.12.003_bb0205","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","volume":"118","author":"Wiviott","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2017.12.003_bb0210","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2017.12.003_bb0215","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijcard.2015.06.023","article-title":"Antiplatelet therapy discontinuation and stent thrombosis after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry","volume":"199","author":"Yano","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0220","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ahj.2014.07.020","article-title":"Mortality after presentation with stent thrombosis is associated with time from index percutaneous coronary intervention: a report from the VA CART program","volume":"168","author":"Armstrong","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2017.12.003_bb0225","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.12.003_bb0230","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Authors\/Task Force Members","year":"2016","journal-title":"Eur Heart J"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062017301652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062017301652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T09:10:38Z","timestamp":1530522638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062017301652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":46,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0033062017301652"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2017.12.003","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2017.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}